SCHEMBL5280182

SCHEMBL5280182

Cc1cnc(-c2ccc(C(F)(F)F)cc2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
THRB P10828 1/20 0.50
KIF11 P52732 5/20 0.47
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
S1PR1 P21453 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
SCN2A Q99250 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31375513 0.84 HDAC4 (0.43) LMNATHRBKIF11ALDH1A1MAPT
SCHEMBL15599291 0.82 NPC1 (0.48) ALDH1A1MAPTNPC1RAB9AKDM4E
SCHEMBL17230034 0.82 ALDH1A1 (0.44) LMNATHRBKIF11ALDH1A1MAPT
SCHEMBL1773246 0.82 NPC1 (0.50) LMNAKIF11ALDH1A1MAPTNPC1
SCHEMBL9951531 0.80 KIF11 (0.57) KIF11ALDH1A1MAPTNPC1HTT
SCHEMBL26375533 0.80 IKBKB (0.41) ALDH1A1MAPTNPC1HTTRAB9A
SCHEMBL4480260 0.80 TRPV1 (0.50) LMNATHRBKIF11ALDH1A1MAPT
SCHEMBL27914438 0.79 KIF11 (0.61) LMNATHRBKIF11ALDH1A1MAPT
SCHEMBL27932659 0.79 CLK4 (0.47) KIF11NPC1RAB9AKDM4EHPGD
SCHEMBL10602510 0.79 KIF11 (0.42) LMNATHRBKIF11ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103626742-B Bi-aryl meta-pyrimidine inhibitors of kinases 塔格根公司 2017-04-26 CN disclosed
EP-1036066-B1 SUBSTITUTED PYRIMIDINE AND PYRIDINE HERBICIDES MID AMERICA COMMERCIALIZATION (US) 2007-04-18 EP disclosed
US-20040033896-A1 E.g., 5-ethyl-4-((3 -(trifluoromethoxy)phenyl)methyl)-2-(3-(trifluoromethyl)-1H pyrazol-1-yl)pyrimidine and 5-methyl-2-(4-(trifluoromethyl)phenyl)-4-((3-(trifluoromethyl) phenyl)methyl)pyrimidine KOETHER GERARD (US) 2004-02-19 US disclosed
US-6525001-B1 5-methyl-2-(4-(trifluoromethyl)phenyl)-4-((3 -(trifluoromethyl)phenyl)methyl)pyrimidine MID-AMERICAN COMMERCIALIZATION CORPORATION 2003-02-25 US disclosed
EP-1036066-A1 SUBSTITUTED PYRIMIDINE AND PYRIDINE HERBICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2000-09-20 EP disclosed
WO-1999028301-A1 SUBSTITUTED PYRIMIDINE AND PYRIDINE HERBICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040033896-A1 E.g., 5-ethyl-4-((3 -(trifluoromethoxy)phenyl)methyl)-2-(3-(trifluoromethyl)-1H pyrazol-1-yl)pyrimidine and 5-methyl-2-(4-(trifluoromethyl)phenyl)-4-((3-(trifluoromethyl) phenyl)methyl)pyrimidine PYM1, Q6ZSR9, MRM1 LMNA 3056/4885THRB 3346/4885KIF11 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.